About Milton Erickson
keefer said the trial is one of the few nih-funded behavioral studies for inflammatory bowel disease, which affects between 250,000 to 500,000 people in the u.s.
keefer said the trial is one of the few nih-funded behavioral studies for inflammatory bowel disease, which affects between 250,000 to 500,000 people in the u.s.